This site is intended for Healthcare Professionals only

New ADHD formulation

Clinical

New ADHD formulation

Atomoxetine hydrochloride (Strattera) is now available as a ready-to-use raspberry-flavoured oral solution for Attention Deficit Hyperactivity Disorder. Strattera offers, according to manufacturer Eli Lilly, a “user-friendly” dosing device “for comfortable and secure administration”. Lilly say they developed the device to improve adherence in patients who, for example, find capsules and tablets difficult to swallow or liquids easier to take.

Copy Link copy link button

Clinical

Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.

Share: